STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

KMDA KAMADA LIMITED StockScouter® Report

6

StockScouter® Score

KAMADA LIMITED, a small cap growth company in the healthcare sector, is expected to slightly outperform the market over the next six months with slightly less than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • One or more less experienced analysts has modestly increased quarterly earnings estimates for KMDA. Positive/Neutral
  • Short-term relative price momentum exhibits moderate strength. Postive/Neutral

 

Concerns

  • Earnings growth in the past year has decelerated moderately compared to earnings growth in the past three years. Negative
  • The most recent quarterly earnings report was slightly lower than analysts’ consensus forecast. Neutral/Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that small cap stocks will be neutral, growth stocks will be in favor, and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 40% done.
Progress: 80% done.
Low
High

Core Model Grades

C
C
C
C

Previous Ratings

8
9
9